Cargando…
Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome
Prader-Willi syndrome (PWS) is a complex, multi-system, neurodevelopmental disorder characterised by neonatal muscular hypotonia, short stature, high risk of obesity, hypogonadism, intellectual disabilities, distinct behavioural/psychiatric problems and abnormal body composition with increased body...
Autores principales: | Höybye, Charlotte, Holland, Anthony J., Driscoll, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869190/ https://www.ncbi.nlm.nih.gov/pubmed/33557878 http://dx.doi.org/10.1186/s13023-020-01651-x |
Ejemplares similares
-
Growth hormone treatment for adults with Prader-Willi syndrome: another point of view
por: Hirsch, Harry J., et al.
Publicado: (2021) -
Approach to the Patient With Prader–Willi Syndrome
por: Höybye, Charlotte, et al.
Publicado: (2022) -
Hyperprolactinemia in Adults with Prader-Willi Syndrome
por: Sjöström, Anna, et al.
Publicado: (2021) -
Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome
por: Shukur, Hasanain Hamid, et al.
Publicado: (2021) -
Twenty Years of GH Treatment in Adults with Prader-Willi Syndrome
por: Sjöström, Anna, et al.
Publicado: (2021)